IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Immunotherapy for Early and Locally-Advanced Non-Small Cell Lung Cancer
March 13, 2018 | Online


Immunotherapy now has become an integral part of the management of advanced NSCLC. There is now an interest in evaluating these agents in the earlier stages of NSCLC.  In this webinar we will:

  • Discuss the current clinical data addressing the use of immunotherapy in patients with early-stage or  locally advanced NSCLC; 
  • Identify ongoing clinical trials assessing the utility of these agents in early and locally advanced NSCLC patients;
  • Demonstrate an update as to the status of next generation  immunotherapeutic agents under clinical development. 

Shirish M. Gadgeel, MD

Mary Lou Kennedy Research Professor in Thoracic Oncology
Co-Leader of Thoracic Oncology Research Program
Associate Director for Cancer Care at Networking and Affiliated Centers
Professor, Department of Internal Medicine, Division of Hematology/Oncology
University of Michigan
Ann Arbor, Michigan


Ramaswamy Govindan, MD - Program Chair

Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology
Washington University School of Medicine